Literature DB >> 16497167

The PAK1 autoregulatory domain is required for interaction with NIK in Helicobacter pylori-induced NF-kappaB activation.

Manfred Neumann1, Anna Foryst-Ludwig, Stefanie Klar, Katrin Schweitzer, Michael Naumann.   

Abstract

Helicobacter pylori, the etiological agent of various human gastric diseases, induces the transcription factor nuclear factor kappaB (NF-kappaB) and proinflammatory cytokines/chemokines. We have characterised the direct interaction between p21-activated kinase 1 (PAK1) and NF-kappaB-inducing kinase (NIK) in H. pylori-infected epithelial cells. The dimerisation (DI) motif, which is part of the NH2-terminal autoregulatory domain of PAK1, is critical for this interaction, whereas NIK forms complexes with PAK1 through its carboxy-terminal IkappaB kinase alpha (IKKalpha) binding site. Since the identified interaction sites are also crucial for the binding of activator (Rac/Cdc42 in the case of PAK1) or effector molecules (IKKalpha in the case of NIK), sequential stepwise signalling is suggested. Furthermore, we show that mitogen-activated protein kinase kinase kinases (MAP3K), like TPL2 (tumour progression locus 2) and transforming growth factor beta-activated kinase 1 (TAK1), have no impact on H. pylori-induced activation of NF-kappaB. These results identify the roles of PAK1 and NIK in a unique pathway involved in H. pylori-induced NF-kappaB activation, which is crucial for the induction of the innate immune response.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16497167     DOI: 10.1515/BC.2006.011

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  13 in total

1.  The many roads traveled by Helicobacter pylori to NFκB activation.

Authors:  Acacia Lamb; Lin-Feng Chen
Journal:  Gut Microbes       Date:  2010-02-23

2.  Tumor cell gene expression changes following short-term in vivo exposure to single agent chemotherapeutics are related to survival in multiple myeloma.

Authors:  Bart Burington; Bart Barlogie; Fenghuang Zhan; John Crowley; John D Shaughnessy
Journal:  Clin Cancer Res       Date:  2008-08-01       Impact factor: 12.531

3.  MicroRNA-377 is up-regulated and can lead to increased fibronectin production in diabetic nephropathy.

Authors:  Qiang Wang; Youli Wang; Andrew W Minto; Jinhua Wang; Qun Shi; Xinmin Li; Richard J Quigg
Journal:  FASEB J       Date:  2008-08-20       Impact factor: 5.191

4.  Helicobacter pylori outer membrane protein HopQ identified as a novel T4SS-associated virulence factor.

Authors:  Elena Belogolova; Bianca Bauer; Malvika Pompaiah; Hiroshi Asakura; Volker Brinkman; Claudia Ertl; Sina Bartfeld; Taras Y Nechitaylo; Rainer Haas; Nikolaus Machuy; Nina Salama; Yuri Churin; Thomas F Meyer
Journal:  Cell Microbiol       Date:  2013-07-15       Impact factor: 3.715

5.  PAK signaling in cancer.

Authors:  Diana Zi Ye; Jeffrey Field
Journal:  Cell Logist       Date:  2012-04-01

6.  Modulation of activation-associated host cell gene expression by the apicomplexan parasite Theileria annulata.

Authors:  Zeeshan Durrani; William Weir; Sreerekha Pillai; Jane Kinnaird; Brian Shiels
Journal:  Cell Microbiol       Date:  2012-05-23       Impact factor: 3.715

7.  Overexpression of PAK1 promotes cell survival in inflammatory bowel diseases and colitis-associated cancer.

Authors:  Vineeta Khare; Kyle Dammann; Mario Asboth; Anita Krnjic; Manuela Jambrich; Christoph Gasche
Journal:  Inflamm Bowel Dis       Date:  2015-02       Impact factor: 5.325

8.  PAK1 modulates a PPARγ/NF-κB cascade in intestinal inflammation.

Authors:  Kyle Dammann; Vineeta Khare; Michaela Lang; Thierry Claudel; Felix Harpain; Nicolas Granofszky; Rayko Evstatiev; Jonathan M Williams; D Mark Pritchard; Alastair Watson; Christoph Gasche
Journal:  Biochim Biophys Acta       Date:  2015-05-31

9.  Republished: tracing PAKs from GI inflammation to cancer.

Authors:  Kyle Dammann; Vineeta Khare; Christoph Gasche
Journal:  Postgrad Med J       Date:  2014-11       Impact factor: 2.401

10.  p21-activated kinase 1 determines stem-like phenotype and sunitinib resistance via NF-κB/IL-6 activation in renal cell carcinoma.

Authors:  Y Zhu; H Liu; L Xu; H An; W Liu; Y Liu; Z Lin; J Xu
Journal:  Cell Death Dis       Date:  2015-02-12       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.